Inflammatory disease of the ileoanal pouch – is it all in the microbiome?

References

• 1. Sharara AI, Al Awadhi S, Alharbi O et al. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev. Gastroenterol. Hepatol. 12(9), 883–897 (2018).
  Medline CASGoogle Scholar
• 2. Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. Br. Med. J. 2(6130), 85–88 (1978).
  Medline CASGoogle Scholar
• 3. oksanen P, Huhtala H, Haapamäki J, aitola P. Health-related quality of life after restorative proctocolectomy: a cross-sectional study. Scand. J. Surg. 107(4), 315–321 (2018).
  MedlineGoogle Scholar
• 4. Shen B, Kochhar GS, El-Hachem S et al. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol. Hepatol. 6(10), 826–849 (2021).
  MedlineGoogle Scholar
• 5. Chowdhry S, Katz JA. Update on the pathogenesis and management of pouchitis. Curr. Infect. Dis. Rep. 16(12), 1–5 (2014).
  Google Scholar
• 6. Falk A, Olsson C, Ahrné S, Molin G, Adawi D, Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand. J. Gastroenterol. 42(8), 973–985 (2007).
  Medline CASGoogle Scholar
• 7. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2), 577–594 (2008).
  Medline CASGoogle Scholar
• 8. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig. Dis. Sci. 39(6), 1193–1196 (1994).
  Medline CASGoogle Scholar
• 9. Shen B, Fazio VW, Remzi FH et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis. Colon Rectum 50(4), 498–508 (2007).
  MedlineGoogle Scholar
• 10. Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124(5), 1202–1209 (2003).
  MedlineGoogle Scholar
• 11. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum 50(12), 2075–2084 (2007).
  MedlineGoogle Scholar
• 12. Persborn M, Gerritsen J, Wallon C et al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment. Pharmacol. Ther. 38(11–12), 772–783 (2013).
  Medline CASGoogle Scholar
• 13. Nicholls RJ, Belliveau P, Neill M, Wilks M, Tabaqchali S. Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut 22(6), 462–468 (1981).
  Medline CASGoogle Scholar
• 14. Santavirta J, Mattila J, Kokki M, Matikainen M. Mucosal morphology and faecal bacteriology after ileoanal anastomosis. Int. J. Colorectal Dis. 6(1), 38–41 (1991).
  Medline CASGoogle Scholar
• 15. H Ruseler-van Embden JG, Schouten WR, C van Lieshout LM. Pouchitis: result of microbial imbalance? Gut 35(35), 658–664 (1994).
  MedlineGoogle Scholar
• 16. Kmiot WA, Youngs D, Tudor R, Thompson H, Keighley MRB. Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br. J. Surg. 80(11), 1445–1449 (2005).
  Google Scholar
• 17. O'Connell PR, Rankin DR, Weiland LH, Kelly KA. Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br. J. Surg. 73(11), 909–914 (1986).
  MedlineGoogle Scholar
• 18. Iwaya A, Iiai T, Okamoto H et al. Change in the bacterial flora of pouchitis. Hepatogastroenterology 53(67), 55–59 (2006).
  MedlineGoogle Scholar
• 19. Kühbacher T, Ott SJ, Helwig U et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55(6), 833–841 (2006).
  Medline CASGoogle Scholar
• 20. McLaughlin SD, Walker AW, Churcher C et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann. Surg. 252(1), 90–98 (2010).
  MedlineGoogle Scholar
• 21. Zella GC, Hait EJ, Glavan T et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel Dis. 17(5), 1092–1100 (2011).
  MedlineGoogle Scholar
• 22. Machiels K, Sabino JJ, Vandermosten L et al. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 66(1), 79–88 (2017).
  MedlineGoogle Scholar
• 23. Maharshak N, Cohen NA, Reshef L, Tulchinsky H, Gophna U, Dotan I. Alterations of enteric microbiota in patients with a normal ileal pouch are predictive of pouchitis. J. Crohn's Colitis 11(3), 314–320 (2017).
  MedlineGoogle Scholar
• 24. Dubinsky V, Reshef L, Bar N et al. Predominantly antibiotic-resistant intestinal microbiome persists in patients with pouchitis who respond to antibiotic therapy. Gastroenterology 158(3), 610–624.e13 (2020).
  Medline CASGoogle Scholar
• 25. Kayal M, Lambin T, Pinotti R, Dubinsky MC, Grinspan A. A systematic review of fecal microbiota transplant for the management of pouchitis. Crohn’s Colitis 360 2(2), otaa034 (2020).
  Google Scholar